Compounds and compositions as protein kinase inhibitors
US8592432B2 · kind B2 · utility
4Cited by
1References
9Claims
0Family size
Inventors
Key dates
| Filing date | Apr 3, 2009 |
| Grant date | Nov 26, 2013 |
| Priority date | — |
| Expiry date | Jan 18, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel pyrimidine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kinase (ALK) activity, c-ros oncogene (ROS), insulin-like growth factor (IGF-1R), and/or insulin receptor (InsR) or a combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.